In the final blog of the series, Dr Manasi Nandi from King’s College London talks about her project where mathematical modelling can help advance the 3Rs by improved analysis of cardiovascular data.

Dr Peter Hohenstein from The Roslin Institute, University of Edinburgh and International Society for Transgenic Technologies, shares his impressions from the 14th Transgenic Technology Meeting.

New approach for inducing stroke in mice reduces variability in the experimental model, offering an opportunity to reduce the number of animals used.

We have teamed up with LabAnimal and the NA3RsC to bring you “3 Minute 3Rs”, a new monthly podcast summarising the latest research and news in 3Rs science and technology.

Researchers from the University of Edinburgh have developed a new system that allows to study Creutzfeldt-Jakob disease (CJD) in vitro for the first time.

Fifteen new PhD studentships have been awarded by the NC3Rs across leading UK institutions for exceptional 3Rs research and training projects.

Mini-tumours have been grown from patient's own tumour cells, with the potential to reduce the number of animals used in liver cancer research.

A new cell-based assay developed with NC3Rs funding replaces the use of animals in pharmaceutical botulinum neurotoxin testing.

We have launched a new version of our guidelines ‘Primate accommodation, care and use’ with updated references and additional information.